# The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and Normoxia

> **NCT01905696** · EARLY_PHASE1 · TERMINATED · sponsor: **Duke University** · enrollment: 10 (actual)

## Conditions studied

- Focus is Determination of the Role of SNO-Hb in Forearm Blood Flow Regulation

## Interventions

- **DRUG:** Oral N-acetylcysteine

## Key facts

- **NCT ID:** NCT01905696
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905696, "The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and Normoxia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01905696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*